Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733453) titled 'The Baerveldt Versus Paul (BvP) Study: a Registry-based Randomised Controlled Trial' on July 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Sydney
Condition:
Glaucoma
Intervention:
Device: Baerveldt Glaucoma Implant
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 12, 2026
Target Sample Size: 150
Countries of Recruitment:
Australia
To know more, visit https://clinicaltrials.gov/study/NCT07733453
Disclaimer: Curated by H...